nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Canrenoate—Prednisone—ankylosing spondylitis	0.297	0.506	CrCtD
Potassium Canrenoate—Prednisolone—ankylosing spondylitis	0.29	0.494	CrCtD
Potassium Canrenoate—Medroxyprogesterone Acetate—Methylprednisolone—ankylosing spondylitis	0.0134	0.033	CrCrCtD
Potassium Canrenoate—Hydrocortamate—Methylprednisolone—ankylosing spondylitis	0.0121	0.0298	CrCrCtD
Potassium Canrenoate—Cortisone acetate—Methylprednisolone—ankylosing spondylitis	0.0117	0.0289	CrCrCtD
Potassium Canrenoate—Hydrocortamate—Prednisone—ankylosing spondylitis	0.011	0.0272	CrCrCtD
Potassium Canrenoate—Hydrocortamate—Prednisolone—ankylosing spondylitis	0.0108	0.0265	CrCrCtD
Potassium Canrenoate—Cortisone acetate—Prednisone—ankylosing spondylitis	0.0107	0.0263	CrCrCtD
Potassium Canrenoate—Cortisone acetate—Prednisolone—ankylosing spondylitis	0.0104	0.0257	CrCrCtD
Potassium Canrenoate—Fluoxymesterone—Dexamethasone—ankylosing spondylitis	0.0103	0.0253	CrCrCtD
Potassium Canrenoate—Fluoxymesterone—Betamethasone—ankylosing spondylitis	0.0103	0.0253	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Methylprednisolone—ankylosing spondylitis	0.0102	0.0251	CrCrCtD
Potassium Canrenoate—Prednisone—Methylprednisolone—ankylosing spondylitis	0.0102	0.0251	CrCrCtD
Potassium Canrenoate—Fluoxymesterone—Triamcinolone—ankylosing spondylitis	0.01	0.0247	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Dexamethasone—ankylosing spondylitis	0.01	0.0247	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Betamethasone—ankylosing spondylitis	0.01	0.0247	CrCrCtD
Potassium Canrenoate—Prednisone—Dexamethasone—ankylosing spondylitis	0.01	0.0247	CrCrCtD
Potassium Canrenoate—Prednisone—Betamethasone—ankylosing spondylitis	0.01	0.0247	CrCrCtD
Potassium Canrenoate—Prednisone—Triamcinolone—ankylosing spondylitis	0.00979	0.0241	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Triamcinolone—ankylosing spondylitis	0.00979	0.0241	CrCrCtD
Potassium Canrenoate—Loteprednol—Methylprednisolone—ankylosing spondylitis	0.00945	0.0233	CrCrCtD
Potassium Canrenoate—Fluoxymesterone—Prednisolone—ankylosing spondylitis	0.00931	0.0229	CrCrCtD
Potassium Canrenoate—Loteprednol—Betamethasone—ankylosing spondylitis	0.00931	0.0229	CrCrCtD
Potassium Canrenoate—Loteprednol—Dexamethasone—ankylosing spondylitis	0.00931	0.0229	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Prednisone—ankylosing spondylitis	0.00929	0.0229	CrCrCtD
Potassium Canrenoate—Loteprednol—Triamcinolone—ankylosing spondylitis	0.00909	0.0224	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Prednisolone—ankylosing spondylitis	0.00907	0.0223	CrCrCtD
Potassium Canrenoate—Prednisone—Prednisolone—ankylosing spondylitis	0.00907	0.0223	CrCrCtD
Potassium Canrenoate—Progesterone—Prednisolone—ankylosing spondylitis	0.00907	0.0223	CrCrCtD
Potassium Canrenoate—Methyltestosterone—Prednisone—ankylosing spondylitis	0.00906	0.0223	CrCrCtD
Potassium Canrenoate—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.00884	0.0218	CrCrCtD
Potassium Canrenoate—Prednisolone—Methylprednisolone—ankylosing spondylitis	0.00865	0.0213	CrCrCtD
Potassium Canrenoate—Loteprednol—Prednisone—ankylosing spondylitis	0.00863	0.0212	CrCrCtD
Potassium Canrenoate—Prednisolone—Dexamethasone—ankylosing spondylitis	0.00851	0.021	CrCrCtD
Potassium Canrenoate—Prednisolone—Betamethasone—ankylosing spondylitis	0.00851	0.021	CrCrCtD
Potassium Canrenoate—Loteprednol—Prednisolone—ankylosing spondylitis	0.00842	0.0207	CrCrCtD
Potassium Canrenoate—Prednisolone—Triamcinolone—ankylosing spondylitis	0.00832	0.0205	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Methylprednisolone—ankylosing spondylitis	0.0083	0.0204	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Betamethasone—ankylosing spondylitis	0.00817	0.0201	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Dexamethasone—ankylosing spondylitis	0.00817	0.0201	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Triamcinolone—ankylosing spondylitis	0.00798	0.0197	CrCrCtD
Potassium Canrenoate—Prednisolone—Prednisone—ankylosing spondylitis	0.00789	0.0194	CrCrCtD
Potassium Canrenoate—Testosterone—Prednisolone—ankylosing spondylitis	0.00787	0.0194	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Prednisone—ankylosing spondylitis	0.00758	0.0187	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Prednisolone—ankylosing spondylitis	0.0074	0.0182	CrCrCtD
Potassium Canrenoate—Gastrointestinal ulcer haemorrhage—Methotrexate—ankylosing spondylitis	0.000418	0.0677	CcSEcCtD
Potassium Canrenoate—Paresthesia of limbs—Methotrexate—ankylosing spondylitis	0.000418	0.0677	CcSEcCtD
Potassium Canrenoate—Ulcer—Triamcinolone—ankylosing spondylitis	0.000128	0.0208	CcSEcCtD
Potassium Canrenoate—Extravasation—Betamethasone—ankylosing spondylitis	0.000126	0.0204	CcSEcCtD
Potassium Canrenoate—Extravasation—Dexamethasone—ankylosing spondylitis	0.000126	0.0204	CcSEcCtD
Potassium Canrenoate—Ulcer—Betamethasone—ankylosing spondylitis	0.000116	0.0189	CcSEcCtD
Potassium Canrenoate—Ulcer—Dexamethasone—ankylosing spondylitis	0.000116	0.0189	CcSEcCtD
Potassium Canrenoate—Ulcer—Prednisone—ankylosing spondylitis	0.000101	0.0164	CcSEcCtD
Potassium Canrenoate—Extravasation—Methotrexate—ankylosing spondylitis	9.18e-05	0.0149	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Prednisolone—ankylosing spondylitis	9.1e-05	0.0147	CcSEcCtD
Potassium Canrenoate—Ulcer—Methotrexate—ankylosing spondylitis	8.47e-05	0.0137	CcSEcCtD
Potassium Canrenoate—Dysarthria—Methotrexate—ankylosing spondylitis	8.47e-05	0.0137	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Triamcinolone—ankylosing spondylitis	8.37e-05	0.0136	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	8.35e-05	0.0135	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Dexamethasone—ankylosing spondylitis	7.59e-05	0.0123	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Betamethasone—ankylosing spondylitis	7.59e-05	0.0123	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Prednisolone—ankylosing spondylitis	6.65e-05	0.0108	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Prednisolone—ankylosing spondylitis	6.62e-05	0.0107	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Prednisone—ankylosing spondylitis	6.61e-05	0.0107	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Triamcinolone—ankylosing spondylitis	6.12e-05	0.00992	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Methylprednisolone—ankylosing spondylitis	6.11e-05	0.0099	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Triamcinolone—ankylosing spondylitis	6.09e-05	0.00987	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Methylprednisolone—ankylosing spondylitis	6.08e-05	0.00985	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Prednisolone—ankylosing spondylitis	5.91e-05	0.00959	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Dexamethasone—ankylosing spondylitis	5.55e-05	0.009	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Betamethasone—ankylosing spondylitis	5.55e-05	0.009	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Dexamethasone—ankylosing spondylitis	5.52e-05	0.00895	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Betamethasone—ankylosing spondylitis	5.52e-05	0.00895	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Triamcinolone—ankylosing spondylitis	5.44e-05	0.00882	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Methylprednisolone—ankylosing spondylitis	5.43e-05	0.0088	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Betamethasone—ankylosing spondylitis	4.94e-05	0.008	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Dexamethasone—ankylosing spondylitis	4.94e-05	0.008	CcSEcCtD
Potassium Canrenoate—Discomfort—Prednisolone—ankylosing spondylitis	4.85e-05	0.00786	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Prednisone—ankylosing spondylitis	4.84e-05	0.00784	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Methotrexate—ankylosing spondylitis	4.82e-05	0.0078	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Prednisone—ankylosing spondylitis	4.81e-05	0.0078	CcSEcCtD
Potassium Canrenoate—Discomfort—Triamcinolone—ankylosing spondylitis	4.46e-05	0.00723	CcSEcCtD
Potassium Canrenoate—Discomfort—Methylprednisolone—ankylosing spondylitis	4.45e-05	0.00721	CcSEcCtD
Potassium Canrenoate—Confusional state—Methylprednisolone—ankylosing spondylitis	4.35e-05	0.00705	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Prednisone—ankylosing spondylitis	4.3e-05	0.00697	CcSEcCtD
Potassium Canrenoate—Infection—Triamcinolone—ankylosing spondylitis	4.3e-05	0.00696	CcSEcCtD
Potassium Canrenoate—Infection—Methylprednisolone—ankylosing spondylitis	4.29e-05	0.00695	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Prednisolone—ankylosing spondylitis	4.22e-05	0.00685	CcSEcCtD
Potassium Canrenoate—Discomfort—Dexamethasone—ankylosing spondylitis	4.05e-05	0.00656	CcSEcCtD
Potassium Canrenoate—Discomfort—Betamethasone—ankylosing spondylitis	4.05e-05	0.00656	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Methotrexate—ankylosing spondylitis	4.04e-05	0.00655	CcSEcCtD
Potassium Canrenoate—Hypotension—Methylprednisolone—ankylosing spondylitis	4.03e-05	0.00654	CcSEcCtD
Potassium Canrenoate—Pain—Prednisolone—ankylosing spondylitis	4.02e-05	0.00652	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Methotrexate—ankylosing spondylitis	4.02e-05	0.00652	CcSEcCtD
Potassium Canrenoate—Infection—Dexamethasone—ankylosing spondylitis	3.9e-05	0.00632	CcSEcCtD
Potassium Canrenoate—Infection—Betamethasone—ankylosing spondylitis	3.9e-05	0.00632	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Triamcinolone—ankylosing spondylitis	3.88e-05	0.0063	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Prednisolone—ankylosing spondylitis	3.88e-05	0.00628	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	3.88e-05	0.00628	CcSEcCtD
Potassium Canrenoate—Pain—Triamcinolone—ankylosing spondylitis	3.7e-05	0.006	CcSEcCtD
Potassium Canrenoate—Hypotension—Dexamethasone—ankylosing spondylitis	3.67e-05	0.00594	CcSEcCtD
Potassium Canrenoate—Hypotension—Betamethasone—ankylosing spondylitis	3.67e-05	0.00594	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	3.56e-05	0.00578	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	3.56e-05	0.00576	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	3.53e-05	0.00572	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Betamethasone—ankylosing spondylitis	3.52e-05	0.00571	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Dexamethasone—ankylosing spondylitis	3.52e-05	0.00571	CcSEcCtD
Potassium Canrenoate—Discomfort—Prednisone—ankylosing spondylitis	3.52e-05	0.00571	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Triamcinolone—ankylosing spondylitis	3.42e-05	0.00554	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	3.41e-05	0.00553	CcSEcCtD
Potassium Canrenoate—Infection—Prednisone—ankylosing spondylitis	3.4e-05	0.0055	CcSEcCtD
Potassium Canrenoate—Pain—Betamethasone—ankylosing spondylitis	3.36e-05	0.00544	CcSEcCtD
Potassium Canrenoate—Pain—Dexamethasone—ankylosing spondylitis	3.36e-05	0.00544	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	3.23e-05	0.00524	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Betamethasone—ankylosing spondylitis	3.23e-05	0.00524	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	3.21e-05	0.0052	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	3.21e-05	0.0052	CcSEcCtD
Potassium Canrenoate—Asthenia—Triamcinolone—ankylosing spondylitis	3.1e-05	0.00503	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Betamethasone—ankylosing spondylitis	3.1e-05	0.00503	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Dexamethasone—ankylosing spondylitis	3.1e-05	0.00503	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Dexamethasone—ankylosing spondylitis	3.1e-05	0.00503	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Betamethasone—ankylosing spondylitis	3.1e-05	0.00503	CcSEcCtD
Potassium Canrenoate—Asthenia—Methylprednisolone—ankylosing spondylitis	3.1e-05	0.00502	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Prednisone—ankylosing spondylitis	3.07e-05	0.00497	CcSEcCtD
Potassium Canrenoate—Rash—Prednisolone—ankylosing spondylitis	2.97e-05	0.00481	CcSEcCtD
Potassium Canrenoate—Dermatitis—Prednisolone—ankylosing spondylitis	2.96e-05	0.0048	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	2.95e-05	0.00479	CcSEcCtD
Potassium Canrenoate—Discomfort—Methotrexate—ankylosing spondylitis	2.94e-05	0.00477	CcSEcCtD
Potassium Canrenoate—Confusional state—Methotrexate—ankylosing spondylitis	2.88e-05	0.00467	CcSEcCtD
Potassium Canrenoate—Infection—Methotrexate—ankylosing spondylitis	2.84e-05	0.0046	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Prednisone—ankylosing spondylitis	2.82e-05	0.00457	CcSEcCtD
Potassium Canrenoate—Asthenia—Dexamethasone—ankylosing spondylitis	2.82e-05	0.00456	CcSEcCtD
Potassium Canrenoate—Asthenia—Betamethasone—ankylosing spondylitis	2.82e-05	0.00456	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	2.8e-05	0.00453	CcSEcCtD
Potassium Canrenoate—Nausea—Prednisolone—ankylosing spondylitis	2.79e-05	0.00453	CcSEcCtD
Potassium Canrenoate—Vomiting—Triamcinolone—ankylosing spondylitis	2.75e-05	0.00446	CcSEcCtD
Potassium Canrenoate—Vomiting—Methylprednisolone—ankylosing spondylitis	2.74e-05	0.00445	CcSEcCtD
Potassium Canrenoate—Rash—Triamcinolone—ankylosing spondylitis	2.73e-05	0.00442	CcSEcCtD
Potassium Canrenoate—Dermatitis—Triamcinolone—ankylosing spondylitis	2.72e-05	0.00442	CcSEcCtD
Potassium Canrenoate—Rash—Methylprednisolone—ankylosing spondylitis	2.72e-05	0.00441	CcSEcCtD
Potassium Canrenoate—Dermatitis—Methylprednisolone—ankylosing spondylitis	2.72e-05	0.00441	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Prednisone—ankylosing spondylitis	2.7e-05	0.00438	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Prednisone—ankylosing spondylitis	2.7e-05	0.00438	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Dexamethasone—ankylosing spondylitis	2.69e-05	0.00435	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Betamethasone—ankylosing spondylitis	2.69e-05	0.00435	CcSEcCtD
Potassium Canrenoate—Hypotension—Methotrexate—ankylosing spondylitis	2.67e-05	0.00433	CcSEcCtD
Potassium Canrenoate—Nausea—Triamcinolone—ankylosing spondylitis	2.57e-05	0.00416	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Methotrexate—ankylosing spondylitis	2.57e-05	0.00416	CcSEcCtD
Potassium Canrenoate—Nausea—Methylprednisolone—ankylosing spondylitis	2.56e-05	0.00415	CcSEcCtD
Potassium Canrenoate—Vomiting—Dexamethasone—ankylosing spondylitis	2.5e-05	0.00404	CcSEcCtD
Potassium Canrenoate—Vomiting—Betamethasone—ankylosing spondylitis	2.5e-05	0.00404	CcSEcCtD
Potassium Canrenoate—Rash—Dexamethasone—ankylosing spondylitis	2.47e-05	0.00401	CcSEcCtD
Potassium Canrenoate—Rash—Betamethasone—ankylosing spondylitis	2.47e-05	0.00401	CcSEcCtD
Potassium Canrenoate—Dermatitis—Dexamethasone—ankylosing spondylitis	2.47e-05	0.00401	CcSEcCtD
Potassium Canrenoate—Dermatitis—Betamethasone—ankylosing spondylitis	2.47e-05	0.00401	CcSEcCtD
Potassium Canrenoate—Asthenia—Prednisone—ankylosing spondylitis	2.45e-05	0.00397	CcSEcCtD
Potassium Canrenoate—Pain—Methotrexate—ankylosing spondylitis	2.44e-05	0.00396	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Methotrexate—ankylosing spondylitis	2.35e-05	0.00382	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Prednisone—ankylosing spondylitis	2.34e-05	0.00379	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	2.34e-05	0.00379	CcSEcCtD
Potassium Canrenoate—Nausea—Betamethasone—ankylosing spondylitis	2.33e-05	0.00378	CcSEcCtD
Potassium Canrenoate—Nausea—Dexamethasone—ankylosing spondylitis	2.33e-05	0.00378	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Methotrexate—ankylosing spondylitis	2.26e-05	0.00366	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Methotrexate—ankylosing spondylitis	2.26e-05	0.00366	CcSEcCtD
Potassium Canrenoate—Vomiting—Prednisone—ankylosing spondylitis	2.17e-05	0.00352	CcSEcCtD
Potassium Canrenoate—Rash—Prednisone—ankylosing spondylitis	2.16e-05	0.00349	CcSEcCtD
Potassium Canrenoate—Dermatitis—Prednisone—ankylosing spondylitis	2.15e-05	0.00349	CcSEcCtD
Potassium Canrenoate—Asthenia—Methotrexate—ankylosing spondylitis	2.05e-05	0.00332	CcSEcCtD
Potassium Canrenoate—Nausea—Prednisone—ankylosing spondylitis	2.03e-05	0.00329	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Methotrexate—ankylosing spondylitis	1.95e-05	0.00317	CcSEcCtD
Potassium Canrenoate—Vomiting—Methotrexate—ankylosing spondylitis	1.82e-05	0.00294	CcSEcCtD
Potassium Canrenoate—Rash—Methotrexate—ankylosing spondylitis	1.8e-05	0.00292	CcSEcCtD
Potassium Canrenoate—Dermatitis—Methotrexate—ankylosing spondylitis	1.8e-05	0.00292	CcSEcCtD
Potassium Canrenoate—Nausea—Methotrexate—ankylosing spondylitis	1.7e-05	0.00275	CcSEcCtD
